QuickView for regulation of RNA polymerase II regulatory region sequence-specific DNA binding (biogroup)

1. Essential thrombocythemia and reactive thrombocytosis platelets compared with healthy controls
2. L1000 CMAP - Kidney epithelial HA1E.101 cells with CRISPR targeted gene knockouts
3. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (2 of 4)
4. L1000 CMAP - Neuronal NEU cells treated with small molecule perturbagens
5. L1000 CMAP - Skeletal muscle SKL.C cells treated with small molecule perturbagens

There were no matches for regulation of RNA polymerase II regulatory region sequence-specific DNA binding

There were no clinical trials for regulation of RNA polymerase II regulatory region sequence-specific DNA binding